EUVIMEDEUVIMED entdecken
Crossref

Integrated Multiomics Analysis and Experimental Validation Identify ITPRIPL1 as an Immunoregulatory and Prognostic Biomarker in Gastric Adenocarcinoma

Zixuan Jia iD, Kangqiao Xiong iD, You Zhou iD, Rong Chen, Daofeng Wang, Shaohang Cai iD, Wei Liao iD

Journal of Gastroenterology and Hepatology · 2026

DOI: 10.1111/jgh.70183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Zixuan Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen Universit…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Scientific Research Project of Traditional Chinese Medicine Bureau of Guangdong Province, Postgraduate Project of the First People's Hospital of Kashi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inositol 1,4,5‐trisphosphate receptor‐interacting protein‐like 1 (ITPRIPL1) has been identified as an inhibitory ligand of CD3ε, but its role in stomach adenocarcinoma (STAD) remains unclear.

Aims

This study aims to elucidate the oncogenic and immunoregulatory roles of ITPRIPL1 in STAD. Materials and Methods Integrative bioinformatic analyses, including transcriptomic and spatial transcriptomic data, were performed to assess ITPRIPL1 expression, prognostic relevance, and immune interactions. Experimental approaches, including proliferation, migration, and invasion assays, were used to validate the functional effects.

Results

We found that ITPRIPL1 was significantly upregulated in STAD and associated with an unfavorable prognosis. Although enriched in T cell activation pathways, ITPRIPL1‐expressing tumor cells predominantly interacted with regulatory T cells (Tregs) and exhausted T cells (Tex), while showing limited communication with cytotoxic or naïve T cells. Spatial analyses revealed positive correlations between ITPRIPL1 expression and both tumor malignancy and T cell exhaustion signatures, but a negative correlation with CD274 expression. Functional assays confirmed the role of ITPRIPL1 in promoting tumor cell proliferation, migration, and invasion.

Discussion

Collectively, ITPRIPL1 promotes STAD progression by increasing tumor aggressiveness and fostering interactions with immunosuppressive T cell subsets.

Conclusion

These findings suggest that ITPRIPL1 is a potential prognostic marker and immunosuppressive target in STAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAdenocarcinomaBiomarkers, TumorHumansPrognosisCell ProliferationCell MovementT-Lymphocytes, RegulatoryCell Line, TumorNeoplasm InvasivenessComputational BiologyUp-RegulationGene Expression Regulation, NeoplasticTranscriptomeMultiomics

Stichwörter der Autor:innen

ITPRIPL1STADmultiomics analysespan‐cancer

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Intensive Care Unit, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • First Division of Intensive Care Unit, First People's Hospital of Kashi, Kashi Prefecture, China.
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Provincial Clinical Research Centre for Cancer, Department of Medical Oncology, Sun Yat-sen University Canc…
  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Key Laboratory of Infectious Diseases Research in South China, Department of Infectious Diseases, Nanfang…

ORCID-Profile: Zixuan Jia, Kangqiao Xiong, You Zhou, Shaohang Cai, Wei Liao

Förderung

  • Scientific Research Project of Traditional Chinese Medicine Bureau of Guangdong Province
  • Postgraduate Project of the First People's Hospital of Kashi

Zitieren

APA

Jia, Z., Xiong, K., Zhou, Y., Chen, R., Wang, D., Cai, S., & Liao, W. (2026). Integrated Multiomics Analysis and Experimental Validation Identify ITPRIPL1 as an Immunoregulatory and Prognostic Biomarker in Gastric Adenocarcinoma. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70183

Vancouver

Jia Z, Xiong K, Zhou Y, Chen R, Wang D, Cai S, et al. Integrated Multiomics Analysis and Experimental Validation Identify ITPRIPL1 as an Immunoregulatory and Prognostic Biomarker in Gastric Adenocarcinoma. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70183

BibTeX
@article{Jia2026,
  author = {Jia, Zixuan and Xiong, Kangqiao and Zhou, You and Chen, Rong and Wang, Daofeng and Cai, Shaohang and Liao, Wei},
  title = {Integrated Multiomics Analysis and Experimental Validation Identify ITPRIPL1 as an Immunoregulatory and Prognostic Biomarker in Gastric Adenocarcinoma},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1111/jgh.70183}
}
Kostenlos starten →